Weekly Recap | Hinge Health +7.12%, closing in on record highsWeekly Review·Sep 19 at 07:54 AMHNGE-0.32%
Weekly Recap | Neogenomics +14.95%, closing in on record highsWeekly Review·Sep 19 at 06:25 AMNEO-2.68%
Weekly Recap | Hims & Hers Health +1.74%, lawsuits and insider selling alongsideWeekly Review·Sep 19 at 06:11 AMHIMS+3.68%HIMZ+6.93%
Weekly Recap | Guardant Health +13.98%, most brokers rate it buyWeekly Review·Sep 19 at 06:09 AMGH+1.89%
Weekly Recap | Elevance Health -1.86%, consensus target above spotWeekly Review·Sep 19 at 06:02 AMELV-1.68%
Weekly Recap | Guardant Health -2.5%, most brokers rate it buyWeekly Review·Sep 12 at 08:18 AMGH+1.89%
Weekly Recap | Hims & Hers Health -0.72%, FTC suit weighsWeekly Review·Sep 12 at 06:02 AMHIMS+3.68%HIMZ+6.93%
Weekly Recap | Hinge Health -4.09%, consensus target above spotWeekly Review·Sep 12 at 06:01 AMHNGE-0.32%
Weekly Recap | Hims & Hers Health -3.92%, FTC suit and class actions in focusWeekly Review·Sep 5 at 07:07 AMHIMS+3.68%HIMZ+6.93%
Weekly Recap | Guardant Health -0.06%, choppy week ends nearly flatWeekly Review·Sep 5 at 06:55 AMGH+1.89%
Weekly Recap | Neogenomics +6.3%, first-profit claim follows volume spikeWeekly Review·Aug 29 at 06:06 AMNEO-2.68%
Weekly Recap | Hims & Hers Health -14.62%, mired in regulatory and legal pressureWeekly Review·Aug 29 at 05:45 AMHIMS+3.68%HIMZ+6.93%
Weekly Recap | HIMS.US +20%, Q2 beat powers breakoutWeekly Review·Aug 22 at 05:05 AMHIMS+3.68%HIMZ+6.93%
